Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mometasone 50micrograms/dose nasal spray
1202010U0AAAAAA
|
Mometasone furoate (Nasal) | Mometasone furoate | Ear, Nose and Oropharynx | 689,115 |
|
Otomize ear spray
120101050BCAAAB
|
Otomize | Dexamethasone | Ear, Nose and Oropharynx | 377,957 |
|
Beclometasone 50micrograms/dose nasal spray
1202010C0AAAAAA
|
Beclometasone dipropionate (Nasal) | Beclometasone dipropionate | Ear, Nose and Oropharynx | 331,151 |
|
Avamys 27.5micrograms/dose nasal spray
1202010W0BBAAAA
|
Avamys | Fluticasone furoate | Ear, Nose and Oropharynx | 218,403 |
|
Fluticasone furoate 27.5micrograms/dose nasal spray
1202010W0AAAAAA
|
Fluticasone furoate | Fluticasone furoate | Ear, Nose and Oropharynx | 208,390 |
|
Fluticasone propionate 50micrograms/dose nasal spray
1202010M0AAACAC
|
Fluticasone propionate (Nasal) | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 147,617 |
|
Beconase Aqueous 50micrograms/dose nasal spray
1202010C0BBABAA
|
Beconase | Beclometasone dipropionate | Ear, Nose and Oropharynx | 130,454 |
|
Dymista 137micrograms/dose / 50micrograms/dose nasal spray
1202010Y0BBAAAA
|
Dymista | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | 125,495 |
|
Benzydamine 0.15% oromucosal spray sugar free
1203010E0AAABAB
|
Benzydamine hydrochloride (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 87,695 |
|
Naseptin nasal cream
1202030S0BBAAAA
|
Naseptin | Neomycin sulfate | Ear, Nose and Oropharynx | 86,293 |
|
Flixonase 50micrograms/dose aqueous nasal spray
1202010M0BBACAC
|
Flixonase | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 76,896 |
|
Fluticasone propionate 50microg/Azelastine 137microg/dose
1202010Y0AAAAAA
|
Fluticasone propionate/azelastine hydrochloride | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | 72,958 |
|
Ciprofloxacin 0.3% / Dexamethasone 0.1% ear drops
1201010AEAAAAAA
|
Ciprofloxacin/dexamethasone | Ciprofloxain/dexameth | Ear, Nose and Oropharynx | 51,731 |
|
Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% cream
1202030S0AAAAAA
|
Neomycin sulfate (Anti-Infective Nasal) | Neomycin sulfate | Ear, Nose and Oropharynx | 47,188 |
|
Benzydamine 0.15% mouthwash sugar free
1203010E0AAAAAA
|
Benzydamine hydrochloride (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 39,934 |
|
Nasofan 50micrograms/dose aqueous nasal spray
1202010M0BCAAAC
|
Nasofan | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 35,051 |
|
Sodium chloride 0.9% neb liq 2.5ml unit dose ampoules
1202020L0AACCCC
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 32,813 |
|
Nasonex 50micrograms/dose nasal spray
1202010U0BBAAAA
|
Nasonex | Mometasone furoate | Ear, Nose and Oropharynx | 30,370 |
|
Chlorhexidine gluconate 0.2% mouthwash
1203040E0AAABAB
|
Chlorhexidine gluconate (Mouthwash) | Chlorhexidine gluconate | Ear, Nose and Oropharynx | 30,330 |
|
Ipratropium bromide 21micrograms/dose nasal spray
1202020I0AAABAB
|
Ipratropium bromide (Nasal) | Ipratropium bromide | Ear, Nose and Oropharynx | 25,191 |
|
Fluticasone 400microgram/unit dose nasal drops
1202010M0AAABAB
|
Fluticasone propionate (Nasal) | Fluticasone propionate (Nasal) | Ear, Nose and Oropharynx | 25,077 |
|
Difflam 0.15% spray
1203010E0BBABAB
|
Difflam (Mouthwash) | Benzydamine hydrochloride | Ear, Nose and Oropharynx | 23,868 |
|
Budesonide 64micrograms/dose nasal spray
1202010I0AAAFAF
|
Budesonide (Nasal) | Budesonide | Ear, Nose and Oropharynx | 20,828 |
|
Mupirocin 2% nasal ointment
1202030R0AAAAAA
|
Mupirocin (Nasal) | Mupirocin | Ear, Nose and Oropharynx | 20,680 |
|
Acetic acid 2% ear spray
1201010B0AAAFAF
|
Acetic acid (Ear) | Acetic acid | Ear, Nose and Oropharynx | 17,310 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.